MXPA03001048A - Polimorfos de zaleplon y metodos para la preparacion de los mismos. - Google Patents

Polimorfos de zaleplon y metodos para la preparacion de los mismos.

Info

Publication number
MXPA03001048A
MXPA03001048A MXPA03001048A MXPA03001048A MXPA03001048A MX PA03001048 A MXPA03001048 A MX PA03001048A MX PA03001048 A MXPA03001048 A MX PA03001048A MX PA03001048 A MXPA03001048 A MX PA03001048A MX PA03001048 A MXPA03001048 A MX PA03001048A
Authority
MX
Mexico
Prior art keywords
zaleplon
preparation
methods
polymorphs
cyanopyrazolo
Prior art date
Application number
MXPA03001048A
Other languages
English (en)
Inventor
Brett Cowans
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of MXPA03001048A publication Critical patent/MXPA03001048A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

Esta invencion se refiere a nuevas formas polimorficas cristalinas de (N-[3-(3-cianopirazoIo[1,5a]pirimidin-7-il) fenil]-N-etilacetamida), metodos para la preparacion de las mismas, y sus usos como agentes ansioliticos, antiepilepticos y sedantes-hipnoticos y relajantes del musculo esqueletico.
MXPA03001048A 2000-08-03 2001-08-02 Polimorfos de zaleplon y metodos para la preparacion de los mismos. MXPA03001048A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22278500P 2000-08-03 2000-08-03
PCT/US2001/024510 WO2002012244A2 (en) 2000-08-03 2001-08-02 Polymorphs of zaleplon and methods for the preparation thereof

Publications (1)

Publication Number Publication Date
MXPA03001048A true MXPA03001048A (es) 2004-02-26

Family

ID=22833666

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03001048A MXPA03001048A (es) 2000-08-03 2001-08-02 Polimorfos de zaleplon y metodos para la preparacion de los mismos.

Country Status (18)

Country Link
US (2) US20020072527A1 (es)
EP (1) EP1305315A2 (es)
JP (1) JP2004505979A (es)
KR (2) KR20070086867A (es)
CN (2) CN1610682A (es)
AR (1) AR036324A1 (es)
AU (2) AU8311901A (es)
BR (1) BR0113244A (es)
CA (1) CA2417875C (es)
HU (1) HUP0303055A3 (es)
IL (1) IL154088A0 (es)
MX (1) MXPA03001048A (es)
NO (1) NO20030523L (es)
NZ (1) NZ527455A (es)
PL (1) PL365678A1 (es)
SG (1) SG125971A1 (es)
WO (1) WO2002012244A2 (es)
ZA (1) ZA200300779B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050032818A1 (en) * 2001-06-12 2005-02-10 Entire Interest N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-5-yl)phenyl]-N-ethylacetamide and crystalline forms of zaleplon
HUP0402257A2 (hu) * 2001-06-12 2005-02-28 BIOGAL Gyógyszergyár Rt. Eljárás az N-[3-(3-cianopirazolo[1,5-a]pirimidin-7-il)-fenil]-N-etil-acetamid (zaleplon) előállítására
CA2453751A1 (en) 2001-08-01 2003-02-13 Biogal Gyogyszergyar Rt. Purification and crystalline forms of zapelon
KR20040086375A (ko) * 2002-02-15 2004-10-08 비오갈 기오기스제르갸르 알티. 소정의 입도 분포를 갖는 잘레플론을 포함하는 분말조성물 및 이로부터 생성된 약학적 생성물
AU2002343201A1 (en) * 2002-10-16 2004-05-04 Sanmar Speciality Chemicals Limited Synthesis of zaleplon
WO2005023813A1 (en) 2003-09-04 2005-03-17 Cipla Limited Zaleplon synthesis
US20070098788A1 (en) * 2005-10-28 2007-05-03 Gore Subhash P Non-benzodiazepine hypnotic compositions
EP1956021A1 (en) * 2006-10-11 2008-08-13 Ferrer Internacional, S.A. Process for the manufacture of a crystalline pyrazolo[1,5-a]pyrimidine compound
WO2010065547A1 (en) * 2008-12-01 2010-06-10 Map Pharmaceuticals, Inc. Inhalation delivery methods and devices
US8555875B2 (en) * 2008-12-23 2013-10-15 Map Pharmaceuticals, Inc. Inhalation devices and related methods for administration of sedative hypnotic compounds
CN102816163A (zh) * 2012-08-20 2012-12-12 四川禾邦阳光制药股份有限公司 扎来普隆的新晶型及制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4626538A (en) * 1983-06-23 1986-12-02 American Cyanamid Company [7-(3-disubstituted amino)phenyl]pyrazolo[1,5-a]pyrimidines
KR0167261B1 (ko) * 1995-10-19 1999-04-15 문정환 전원공급 제어회로
US5714607A (en) * 1995-12-01 1998-02-03 American Cyanamid Company Process improvement in the synthesis of N- 3-(3-cyano-pyrazolo 1,5-a!pyrimidin-7-yl)phenyl!-N-ethylacetamide
AR029780A1 (es) * 2000-12-13 2003-07-16 Gador Sa Procedimiento mejorado para la obtencion de n-[3(3-ciano-pirazolo[1,5-a]pirimidin-7-il)fenil]-n-etil-acetamida
CA2453751A1 (en) * 2001-08-01 2003-02-13 Biogal Gyogyszergyar Rt. Purification and crystalline forms of zapelon

Also Published As

Publication number Publication date
CN1847244A (zh) 2006-10-18
CA2417875A1 (en) 2002-02-14
WO2002012244A2 (en) 2002-02-14
US20020072527A1 (en) 2002-06-13
HUP0303055A2 (hu) 2004-01-28
SG125971A1 (en) 2006-10-30
BR0113244A (pt) 2003-07-08
KR20030036659A (ko) 2003-05-09
AU8311901A (en) 2002-02-18
IL154088A0 (en) 2003-07-31
KR20070086867A (ko) 2007-08-27
JP2004505979A (ja) 2004-02-26
WO2002012244A3 (en) 2002-06-13
NO20030523L (no) 2003-03-11
US20050176735A1 (en) 2005-08-11
AU2001283119B2 (en) 2007-11-15
CN1610682A (zh) 2005-04-27
CA2417875C (en) 2008-12-09
PL365678A1 (en) 2005-01-10
EP1305315A2 (en) 2003-05-02
HUP0303055A3 (en) 2004-11-29
AR036324A1 (es) 2004-09-01
ZA200300779B (en) 2003-08-22
NO20030523D0 (no) 2003-02-03
NZ527455A (en) 2005-07-29

Similar Documents

Publication Publication Date Title
TNSN05058A1 (en) Novel polymorph of n-methyl-n-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-alpha]-pyrimidin-7-yl}phenyl) acetamide and compositions and methods related thereto
HK1061684A1 (en) Intermediates for the preparation of certain triazolopyrimidines as p2t antagonists
SG170783A1 (en) Pyrrolo[2,3-d]pyrimidine derivatives; their intermediates and synthesis
CA2191647A1 (en) Process improvement in the synthesis of n-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-n-ethylacetamide
DE60326060D1 (de) Nichtvernetzende pyrroloä2,1-cüä1,4übenzodiazepine als potentielle antitumor-agentien und ihre herstellung
MXPA03001048A (es) Polimorfos de zaleplon y metodos para la preparacion de los mismos.
HK1083844A1 (en) N-[3-(3-substituted-pyrazolo[1,5-a] pyrimidin-7-yl) phenyl]-sulfonamides, and compositions, and methods related thereto
IL160076A0 (en) Process for purifying n-[3-(3-cyanopyrazolo{1,5-a} pyrimidin-7-yl) phenyl]-n-ethylacetamide (zaleplon) and crystalline forms of zaleplon accessible with the process
PL372942A1 (en) Process for the production of n-[3-(3-cyanopyrazolo[1,5-a] pyrimidin-7-yl)phenyl]-n-ethylacetamide (zaleplon)
IL148078A0 (en) A method for the synthesis of substituted pyrazolopyrimidines
IL144516A0 (en) PROCESS FOR THE PREPARATION OF PYRAZOLO [4,3-d] PYRIMIDIN-7-ONE COMPOUNDS AND INTERMEDIATES THEREOF
AP1631A (en) Polymorphs of N-methyl-N- (3- {3- [2-thienylcarbonyl] -pyrazol- [1,5-?] -pyrimidin-7-yl} phenyl) acetamide and compositions and methods related thereto.
DE69910574D1 (de) Pyrazolo[1,5-a]triazine als crf antagonisten
GB2425309A (en) C2-fluoro pyrrolo[2,1-c][1,4]benzodiazepine dimers
AU2003223107A1 (en) Pyrene-linked pyrrolo (2,1-c) (1,4) benzodiazepine derivatives useful as anticancer agents
WO2006070244A3 (en) A process for the preparation of zaleplon
EA200300220A1 (ru) Способ получения имидазо[1,2-c][2,3]бензодиазепинов и получаемые по этому способу промежуточные продукты
WO2008068600A3 (en) An improved process for the preparation of zaleplo
AU2003243061A1 (en) A process for the preparation of zaleplon
EP1344768A3 (en) Synthesis of substituted pyrazolopyrimidines
HUP0400325A3 (en) Pure n-[3-(-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-n-ethyl-acetamide, process for its preparation and intermediates
WO2003011298A8 (en) Antibacterial oxazinones and methods for their use and synthesis
TNSN05325A1 (en) N-[3-(3-SUBSTITUTED-PYRAZOLO[1,5-a]PYRIMIDIN-7-YL)PHENYL]-SULFONAMIDES, AND COMPOSITIONS, AND METHODS RELATED THERETO
GB0107526D0 (en) Process for the preparation of pyrazolo [4,3-d] pyrimidin-7-one compounds and intermediates thereof
GB0110251D0 (en) Process for the preparation of pyrazolo[4,4-d]Pyrimidin-7-one compounds and intermediates thereof

Legal Events

Date Code Title Description
FA Abandonment or withdrawal